GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
ACTIVE_NOT_RECRUITING
Status
Conditions
- Adult Solid Neoplasm
- Pancreatic Acinar Cell Carcinoma
- Pancreatic Ductal Adenocarcinoma
- Recurrent Pancreatic Carcinoma
- Stage IV Pancreatic Cancer AJCC v6 and v7
Interventions
- OTHER: Diagnostic Laboratory Biomarker Analysis
- DRUG: Erlotinib Hydrochloride
- DRUG: Gemcitabine Hydrochloride
- DRUG: Vismodegib
Sponsor
National Cancer Institute (NCI)